Skip to main content

Wyeth-Ayerst Plans Vaccine Development Center

Published 1/9/2002

 Wyeth-Ayerst has commissioned Ewing Cole Cherry Brott of Philadelphia in collaboration with Fluor Daniel to provide architecture and engineering services for a new vaccine development center. The building will consolidate the company's vaccine development centers currently located throughout the United States, reducing product development and manufacturing cycle time. It will include development process labs, analytical labs, various levels of biocontainment space, a research library, conference center, offices, and an employee cafeteria. Construction is expected to begin in May 2002 with an estimated completion date of first quarter 2004.